/ Peptide Library
Searchable research database.
Filter by biological system or evidence type. Each card opens a research profile — mechanism, evidence, and studied contexts.
Control Deck
21 compounds matched
Semaglutide
GLP-1 receptor agonist studied for glycemic and weight research.
Tirzepatide
Dual GIP/GLP-1 agonist studied in metabolic research.
Tesamorelin
GHRH analog studied for visceral adiposity research.
SS-31
Elamipretide
Mitochondrially-targeted tetrapeptide studied for cardiolipin interaction.
BPC-157
Pentadecapeptide studied for tissue protection and repair models.
GHK-Cu
Copper-binding tripeptide studied in regenerative biology.
Sermorelin
GHRH analog studied for endogenous GH signaling.
Cerebrolysin
Neuropeptide preparation studied in neuroregeneration research.
LL-37
Cathelicidin antimicrobial peptide studied in immune research.
AOD-9604
Fragment of hGH (176-191) studied in lipid metabolism research.
CJC-1295
Long-acting GHRH analog studied in GH signaling research.
Ipamorelin
Selective GH secretagogue studied for ghrelin receptor signaling.
MOTS-c
Mitochondrial-derived peptide studied in AMPK signaling research.
TB-500
Thymosin Beta-4 fragment
Synthetic fragment studied for cell migration and tissue remodeling.
KPV
Tripeptide fragment of α-MSH studied for inflammatory modulation.
Retatrutide
Triple agonist (GLP-1, GIP, glucagon) studied in metabolic trials.
Semax
Synthetic ACTH(4-10) analog studied in neurotrophic research.
Selank
Synthetic tuftsin analog studied in anxiolytic-like research.
Dihexa
Angiotensin IV analog studied in synaptogenesis research.
Epitalon
Tetrapeptide studied in telomerase/aging research.
FOXO4-DRI
Peptide studied in senescent-cell research models.
For research and educational purposes only.
Not medical advice. Not intended to diagnose, treat, cure, or prevent disease. Compounds discussed may not be approved for human use. Any dosing information shown describes ranges studied in research settings — never a recommendation.